Clinical use of AH8165 (Fazadinium).
D002302:Cardiac Output / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007674:Kidney Diseases / Q000150:complications; D009132:Muscles / Q000187:drug effects*; D010197:Pancuronium / Q000494:pharmacology; D011726:Pyridinium Compounds / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D013390:Succinylcholine / Q000494:pharmacology; D013997:Time Factors; D014403:Tubocurarine / Q000494:pharmacology
D011726:Pyridinium Compounds; D013390:Succinylcholine; D010197:Pancuronium; D014403:Tubocurarine